• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Encephalitis, Tick-Borne

Encephalitis, Tick-Borne - 24 Studies Found

Active, not recruiting : Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
: Encephalitis, Tick-Borne
: 2009-04-30
: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
Completed : TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)
: Encephalitis, Tick-Borne
: 2005-09-08
: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Subjects receive one vaccination with ei
Completed : Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children
: Encephalitis, Tick-Borne
: 2009-02-09
:
  • Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Completed : TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
: Encephalitis, Tick-Borne
: 2007-07-17
: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Vaccination by intramuscular injection i
Completed : Tick-borne Encephalitis and Positive Borrelial Antibodies
: Tick-borne Encephalitis
: 2014-07-20
:
  • Drug: Doxycycline Beside sympt

Completed : Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
: Tick-Borne Encephalitis
: 2005-07-08
:
  • Biological: LGT(TP21)/DEN4 Liv

Completed : Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
: Tick Borne Encephalitis
: 2012-03-13
: Other: Blood Sampling Annual blood draws
Completed : Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
: Encephalitis, Tick-borne
: 2005-09-08
: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
Completed : Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
: Encephalitis, Tick-borne
: 2005-09-08
: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
Completed : Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
: Encephalitis, Tick-borne
: 2005-09-08
: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.